Dark Mode Light Mode

‘I’m not worried about tariffs for Novo Nordisk .’Lars Jørgensen CEO

Spread the love


NOVO NORDISK (NVO) is not concerned about the ongoing US trade war, and 25%of tariffs will be implemented for pharmaceutical companies next week.

Lars Jørgensen CEO said to journalists on Thursday, “I’m not worried about tariffs for Novo Nordisk.”

He pointed out that the company already has a globalized setting for manufacturing near the market where the product is sold, including the active pharmaceutical ingredient (API), which is the basic ingredient of drug formula. APIs are mainly produced in China, but NOVO produces APIs only in the United States and Denmark, he said.

Jørgensen said, “We have products that move across the border and actually reduce the products in different ways in a world with a lot of tariffs and, of course, can reduce cross -borders.”

He added that the US market relies heavily on general pharmaceuticals than brand products that Novo Nordes do not sell.

NYSE-Delayed Mt. USD

Close: March 7 4:00:02 EST

Competitor ELI Lilly (Lly) recently announced $ 27 billion investments in US manufacturing, including APIs. It is not known yet.

File Photo: September 26, 2023 The logo of Danish pharmaceutical Novo Nordis in the office of Healer Road, Denmark. Reuters/Tom Little/File Photo
File Photo: September 26, 2023 The logo of Danish pharmaceutical Novo Nordis in the office of Healer Road, Denmark. Reuters/Tom Little/File Photo · · Reuters / Reuters

LILLY has recently built a new manufacturing site in North Carolina to produce GLP-1 injectable pen. NOVO is already in North Carolina and has an API production site worth $ 2.5 billion and is near the next stage of the supply chain ($ 4.1 billion filled factory).

The process of the API helps to grow biological products using yeast fermentation, and it is a cost -effective investment, Jørgensen includes a large tank that continues to produce ingredients in the process of API, Jørgensen said.

“It’s given that you can’t spread small facilities all over the world. Because you won’t reach the same scale, I’m very comfortable for that settings and it’s very comfortable to supply the US market in that setting.”

“I’m not especially worried about the impact of tariffs on Novo Nordic.”

Anjalee Kachmli Yahoo Finance’s senior health journalists deal with everything that deals with pharmaceuticals, insurance, nursing services, digital health, PBM and health policy and politics. Of course, GLP-1 and tariffs are included. Follow Anjalee in Social Media Platform X, LinkedIn and BlueSky. @anjkhem.

Click here for in -depth analysis of the latest health industry news and events affecting stock prices.





Source link

Keep Up to Date with the Most Important News

By pressing the Subscribe button, you confirm that you have read and are agreeing to our Privacy Policy and Terms of Use
Add a comment Add a comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Dad speaks after a four -year -old daughter received a serious complication from the flu.

Next Post

The second person dies by the onset of measles in the United States